A chemoresistance lncRNA signature for recurrence risk stratification of colon cancer patients with chemotherapy

Chemotherapy is considered the nonsurgical treatment of choice for colon cancer patients. However, no precise molecular markers are available to determine which patients can actually benefit from it. In this study, we identified 55 chemotherapy-specific long non-coding RNAs (lncRNAs) of colon cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hao, Gao, Yuzhen, Vafaei, Somayeh, Yu, Qiaoyan, Zhang, Jun, Wang, Liangjing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733234/
https://www.ncbi.nlm.nih.gov/pubmed/35036055
http://dx.doi.org/10.1016/j.omtn.2021.12.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733234/
https://www.ncbi.nlm.nih.gov/pubmed/35036055
http://dx.doi.org/10.1016/j.omtn.2021.12.015

Ejemplares similares